Galera Therapeutics is focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer.
View Top Employees from Galera Therapeutics, Inc.Website | http://www.galeratx.com |
Ticker | GRTX |
Revenue | $8 million |
Employees | 40 (40 on RocketReach) |
Founded | 2009 |
Address | 2 W Liberty Blvd, Malvern, Pennsylvania 19355, US |
Phone | (610) 725-1500 |
Technologies |
JavaScript,
HTML,
PHP
+29 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Business Services General, Biotechnology, Business Services, Science and Engineering, Life Science, Therapeutics, Health Care |
Web Rank | 11 Million |
Keywords | Contact Us Email Pennsylvania Therapeutics, Philadelphia Oncology Biotech, Superoxide Dismutase Mimetics For Sale Galera, Superoxide Dismutase Mimetics For Sale, Galera Therapeutics |
Competitors | Annexon Biosciences, Diffusion Pharmaceuticals, Frequency Therapeutics, Precision Biologics, Synthorx Inc |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 541714 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies |
Looking for a particular Galera Therapeutics, Inc. employee's phone or email?
The Galera Therapeutics, Inc. annual revenue was $8 million in 2024.
Chris Degnan is the CFO of Galera Therapeutics, Inc..
40 people are employed at Galera Therapeutics, Inc..
Galera Therapeutics, Inc. is based in Malvern, Pennsylvania.
The NAICS codes for Galera Therapeutics, Inc. are [541, 54171, 541714, 5417, 54].
The SIC codes for Galera Therapeutics, Inc. are [87, 873].